All studies
Active not recruitingNAINTERVENTIONAL

First in Human Clinical Investigation of the FIRE1 System in Heart Failure Patients (FUTURE-HF)

This study is called FUTURE-HF and is looking into a new device, the FIRE1 System, for people living with heart failure. We're inviting up to 50 patients to take part. This is the very first time this device will be tested in people. The main goals are to check if it's safe to put into the body and if it works properly. We'll be keeping a close eye on all participants for any side effects over 3 months, and they will stay in the study for a total of 24 months. We hope this research could help develop new ways to manage heart failure in the future.

At a glance

Status
Active not recruiting
Phase
NA
Sponsor
Foundry Innovation & Research 1, Limited (FIRE1)
Enrolment target
50
Start
22 Nov 2019
Estimated completion
30 Sep 2029

What is this study about?

Heart failure is a condition where your heart isn't pumping blood around your body as well as it should. This can lead to symptoms like breathlessness, tiredness, and swollen ankles. This particular study is evaluating a new system, called FIRE1, which is designed to help manage heart failure. This is the first time this system is being used in humans, so we're starting with a small group of patients to understand its effects.

The main purpose of this study is to see if the FIRE1 system can be safely put into the body and whether it works as expected. We'll be looking very closely at how well patients tolerate the device and if there are any side effects. This initial step is really important for developing new treatments, as it helps us understand if a new approach is both safe and has the potential to be helpful for patients.

By taking part, you would be contributing to vital research into heart failure. The information we gather will help doctors and researchers learn more about how this new system performs. This knowledge could eventually lead to new options for people living with heart failure in the future, potentially improving their quality of life.

Key takeaways

  • This is the first human study of a new heart failure device (FIRE1 System).
  • It aims to check the safety and how well the device works in 50 patients.
  • Participation lasts 24 months, with close monitoring for the first 3 months.
  • You must be an adult with heart failure who recently had worsening symptoms.
  • You can withdraw from the study at any time without affecting your care.
  • Your participation could help advance future heart failure treatments.

Who may be eligible?

This study is looking for adults aged 18 or over who have been diagnosed with heart failure. To be considered, you should have experienced a worsening of your heart failure that required hospitalisation, treatment in a hospital day-care, or an urgent clinic visit within the last six months. It’s also important that your current heart failure treatment follows standard medical guidelines.

There are also some reasons why you might not be able to join. For example, if you have other serious health problems that might make it unsafe for you to take part, or if you have very poor kidney function. We also can't include people who have certain medical devices already implanted, or if you have specific issues with the large vein in your abdomen (the IVC) or in your legs.

We will also check if you have an implanted heart device that was put in very recently (within the last three months). If any of these apply to you, you might not be suitable for this particular study. The study team will discuss all these points with you to make sure it's the right fit.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you 18 years old or older?
  2. Do you have heart failure?
  3. Have you been hospitalised, treated in day-care, or had an urgent clinic visit for your heart failure in the last 6 months?
  4. Are you currently receiving standard medical treatment for your heart failure?
  5. Do you have any other serious health conditions that might make surgery risky or prevent you from completing study visits?
  6. Do you have very poor kidney function (eGFR below 30)?
Answer every question to see your result.

What does participation involve?

If you decide to take part, you would first have a full health check to make sure the study is right for you. This would involve signing a consent form. While the exact details of what putting the device in will involve aren't fully described, you should expect it to be a medical procedure that will require some hospital time. After the device is put in, you will be followed very closely by the study team, especially for the first 3 months. During this time, they will monitor your health and check for any side effects or problems with the device. You will also have regular check-ups and assessments, which might involve clinic visits or other tests to track your progress. The study aims to follow you for a full 24 months to understand the long-term effects. The study team will provide you with a detailed schedule of visits and what to expect.

Potential risks and benefits

Taking part in a study like this comes with potential benefits and risks. The potential benefit is that you would be receiving a new device that might help manage your heart failure, although this is not guaranteed, as it's an early-stage study. You would also be contributing to important medical research that could help others in the future. Potential risks include those associated with any medical procedure, such as infection, bleeding, or issues related to the device itself. The study team will carefully monitor you for any problems. It's very important to remember that you are free to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Locations (13)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • Nemocnice Na Homolce
    Verified postcode
    Prague, Czechia
  • Fakultní Nemocnice Brno
    Verified postcode
    Brno, Czechia
  • Israeli-Georgian Medical Research Clinic Helsikor
    Verified postcode
    Tbilisi, Georgia
  • Tbilisi Heart and Vascular Clinic
    Verified postcode
    Tbilisi, Georgia
  • Galway University Hospital
    Verified postcode
    Galway, Ireland
  • Erasmus University Medical Center
    Verified postcode
    Rotterdam, Netherlands
  • University Medical Center, Groningen
    Verified postcode
    Groningen, Netherlands
  • Royal Bournemouth Hospital
    Verified postcode
    Bournemouth, United Kingdom
  • Golden Jubilee National Hospital
    Verified postcode
    Glasgow, United Kingdom
  • Glenfield Hospital
    Verified postcode
    Leicester, United Kingdom
  • Royal Brompton Hospital Sydney Street
    Verified postcode
    London, United Kingdom
  • Queen Alexandra Hospital
    Verified postcode
    Portsmouth, United Kingdom

Common questions

What is the FIRE1 System?

The FIRE1 System is a new device being tested to see if it can help people with heart failure. This study is the first time it's being used in humans.

How long will I be in the study?

You'll be in the study for a total of 24 months. For the first 3 months, you'll be very closely monitored for safety.

Will I have to stay in the hospital?

Yes, you should expect some hospital time for the procedure to put the device in. The study team will give you more details on that.

Who can't join this study?

People with certain other serious health issues, very poor kidney function, or some existing implanted devices might not be able to join. The study team will check this carefully.

Can I leave the study at any time?

Yes, you can leave the study at any point, for any reason, and your medical care won't be affected.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.